Info
Brain Talks is a podcast produced by Brain Innovation Days, the online community of key opinion leaders and stakeholders from the ever-growing brain innovation ecosystem.
Find more on braininnovationdays.eu
Find more on braininnovationdays.eu
4 NOV 2024 · As the EU Health Technology Assessment (HTA) landscape transforms with the upcoming Joint Clinical Assessment (JCA), what does this mean for timely access to innovative therapies and reducing duplication of efforts across Member States?
In this episode, Frédéric Destrebecq, Executive Director of the European Brain Council, sat down with Dr. Dimitrios Georgiopoulos, Senior Vice President and Global Franchise Head for Neurology & Immunology at Merck Healthcare, to discuss the opportunities and challenges of the new Health Technology Assessment Regulation, particularly for orphan and neurological treatments. Join us to explore how this new framework aims to harmonize methodologies, empower patient engagement, and shape a collaborative future for healthcare across the EU.
28 OCT 2024 · Neurodegenerative disorders have a huge societal burden and heavily impact the lives of those affected. Artificial intelligence (AI) in healthcare is a booming field: the development of computer programs and systems able to emulate tasks normally requiring human intelligence such as recognizing patterns, taking decisions, evaluating and predicting is set to revolutionize the prevention and care of people with neurodegenerative disorders.
In this Brain Talks episode, Sam Pauly is joined by Dr Alessandro Guazzo, Postdoctoral Fellow at Carnegie Mellon University and Dr Ira Haraldsen, Primary investigator and Head of the Cognitive Health Research group at the Oslo University Hospital.
17 OCT 2024 · Welcome to Season 4 of Brain Talks!
In this first episode, join our host Sam Pauly with special guests: Lisa Burke, Master of Ceremony for the 4th edition of the Brain Innovation Days, and Frédéric Destrebecq, Executive Director of the European Brain Council.
Discover exclusive insights on the event’s brand new theme, “Navigating the Brain Across a Lifetime,” learn more about the programme, but also its key sessions, new interactive experiences, and much more!
20 JUN 2024 · The increasing number of people living with two or more chronic disorders (multimorbidities) poses an urgent need to better understand underlying mechanisms for better prevention and care throughout the life course. Somatic disorders e.g., type 2 diabetes and brain disorders e.g., Alzheimer’s disorder often co-occur. If a single molecule was the key to some of the greatest health challenges of our time, what would tomorrow look like?
The EU-funded PRIME project aims to unravel the insulin-dependent mechanisms underlying both somatic conditions (e.g., type 2 diabetes, obesity, metabolic syndrome) and brain disorders (e.g., Alzheimer’s disease, obsessive-compulsive disorder, autism spectrum disorders).
In this new Brain Talks episode on the integration of mental and somatic health, Sam Pauly sat down with two partners in this EU-funded project https://prime-study.eu/: Silke Matura, Group Leader at the Goethe University Hospital, and Simone Macri, Researcher at the Italian National Institute of Health.
14 MAR 2024 · The Covid-19 pandemic shed a crude light on how instrumental research and innovation are in the European Union. This crisis revealed significant disparities and fractures between Member States. More importantly, patients living with neurological or mental disorders were heavily impacted by the pandemic, and faced tremendous challenges to maintain their access to care and to meet their medical needs.
In this episode, Frederic Destrebecq, Executive Director of the European Brain Council, Christian Suojanen, Founder & CEO of Broadreach Global, and Professor Michel Goldman, renowned medical doctor and researcher, discuss the post-pandemic European landscape, and address the major challenges and opportunities for brain research and innovation in the EU.
From fostering a collaborative climate within the wider brain community to an ambitious European Brain Research and Innovation Plan, join our journey on what it takes to make brain research and innovation a European priority for the 21st century.
15 FEB 2024 · This Brain Talks episode on Urban Environment and Brain Health features two projects on brain health, funded by the European Union under the same main programme (H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being): https://brainteaser.health/ and https://emotionalcities-h2020.eu/.
Evidence shows that environmental factors may influence both the aetiology and the progression of a number of brain conditions. Through cost-effective sensors and apps, a comprehensive analysis of clinical, lifestyle and environmental data and predictive/preventive AI models for patient stratification and disease progression, BRAINTEASER aims to better inform people living with MS and ALS and support clinical decision making in 4 urban areas: Madrid, Turin, Lisbon and Pavia.
Urban living is associated to an increase in mood and anxiety disorders, drugs addiction and risk of schizophrenia and psychosis. Through urban stress research, emotional mapping, urban prevention and therapy research, eMOTIONAL Cities aims to explore how urban planning and design could positively impact brain health in 4 cities: Lisbon, Copenhagen, London and Lansing.
1 DEC 2023 · Despite the burden, migraine is not consistently recognized in health policy. However, countries are making progress and establishing a way forward for patients.
In the latest Brain Talks episode, Sam Pauly sat down with Dawn Carlson, AbbVie's Vice-President of Neuroscience Clinical Development, and Alessandra Sorrentino, migraine patient and representative of Alleanza Cefalalgici, to discuss promising developments in migraine care, management, and policy prioritization.
This episode was recorded in partnership with AbbVie.
21 NOV 2023 · In this third episode of Brain Talks | Season 3, Alice Medialia (Columbia University), Péter Kéri (GAMIAN-Europe), and John Saunders (EUFAMI) sat down with Sam Pauly to share some thoughts and advices on how to ensure the meaningful engagement of patients with lived experiences of mental health conditions.
In partnership with Boehringer Ingelheim, this episode was recorded live from the third edition of the Brain Innovation Days
4 OCT 2023 · Join us for the second episode of this new season of Brain Talks, where Dimitrios Georgiopoulos, Global Business Franchise Head for Neurology and Immunology at Merck Healthcare, delves into the world of Multiple Sclerosis (MS) care.Discover Merck's patient-centered approach and explore the challenges and opportunities for young people living with MS in the EU. With 2.9 million people affected, this is a conversation that impacts us all.
11 SEP 2023 · Brain Talks are back for a third season!
Join us in unveiling the highly anticipated 2023 edition of the Brain Innovation Days with Prof. Suzanne Dickson, President of the European Brain Council, and Frédéric Destrebecq, Executive Director of EBC.
Brain Talks is a podcast produced by Brain Innovation Days, the online community of key opinion leaders and stakeholders from the ever-growing brain innovation ecosystem.
Find more on braininnovationdays.eu
Find more on braininnovationdays.eu
Information
| Author | Brain Innovation Days |
| Organization | Brain Innovation Days |
| Categories | Medicine |
| Website | - |
| - |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
